Related Experiment Video
Updated: Jun 3, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation
Xiaoming Li1, William W B Wang, Guanghan F Liu
1Merck Research Laboratories, North Wales, Pennsylvania, USA.
Journal of Biopharmaceutical Statistics
|March 11, 2011
Summary
Missing data is common in vaccine clinical trials. This study presents statistical methods to address missing data in vaccine immunogenicity and safety analyses, using simulations and trial examples.
Area of Science:
- Clinical Trials
- Vaccinology
- Biostatistics
Background:
- Missing data is an inevitable challenge in clinical trials, arising from participant dropout or loss to follow-up.
- Effective handling of missing data is crucial for accurate interpretation of clinical trial results.
- Vaccine trials present unique challenges for managing missing data compared to traditional pharmaceutical trials.
Purpose of the Study:
- To present statistical approaches for analyzing vaccine immunogenicity and safety data with missing values.
- To highlight the specific considerations for missing data in vaccine clinical trials.
- To provide practical guidance through simulations and real-world examples.
Main Methods:
- Review of statistical methodologies for handling missing data in clinical trial settings.
- Application of these methods to vaccine immunogenicity and safety data.
- Illustration using numerical simulations and case studies from vaccine trials.
Main Results:
- Demonstration of various statistical techniques effectively addressing missing data in vaccine trials.
- Quantification of the impact of missing data on immunogenicity and safety outcomes.
- Validation of proposed methods through comparative analyses.
Conclusions:
- Statistical methods are essential for robust analysis of vaccine trials with missing data.
- Proactive planning for missing data at the study design stage is recommended.
- The presented approaches offer valuable tools for researchers conducting vaccine clinical trials.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:51Vaccinations
Overview
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...